(Reuters) – British scientists have developed a lightweight and highly sensitive brain imaging device that can be worn as a helmet, allowing the patient to move about naturally.

(Reuters) – Endo International Plc and two other companies have agreed to pay $270.8 million to resolve class action lawsuits alleging Endo paid a generic drug manufacturer to delay launching a cheaper version of its Lidoderm painkiller patch.

CHICAGO (Reuters) – Longtime AIDS researcher Dr. Robert Redfield will be the new director of the Centers for Disease Control and Prevention in Atlanta, the administration of U.S. President Donald Trump announced on Wednesday.

(Reuters Health) – Carefully following a gluten-free diet might not protect people with celiac disease from exposure to potentially harmful amounts of gluten, new findings suggest.

(Reuters Health) – Mass-produced shoe inserts available on drugstore shelves and customized orthotics may not work for plantar heel pain, a research review suggests.

(Reuters Health) – Infant mortality rates for full-term babies vary across the U.S., but all states are worse than many European countries, a new study suggests.

LONDON (Reuters) – Cut-price copies of an expensive Roche biotech drug for blood cancer have taken 80 percent of the British market since launching last year, saving the healthcare system 80 million pounds ($113 million) a year, experts said on Wednesday.

HAMBURG (Reuters) – German authorities have confirmed outbreak of the highly pathogenic H5N6 bird flu type at a farm on an island off the German North Sea coast, the Schleswig-Holstein state agriculture ministry said on Wednesday.

LONDON (Reuters) – In January, GlaxoSmithKline’s new head of pharmaceuticals Luke Miels issued a blunt challenge to his managers: find budget savings of 20 percent.